Calciphylaxis-associated pannicular wounds in end-stage renal disease: Recurrent disease, massive adiposenecrosis, and eventual resolution through multidisciplinary management

Authors

Kevin D. Nolan, MD, MPH, FSVS, FACS, FAPWCA, UHMS¹
William H. Tettelbach, MD, FACP, FIDSA, FUHM, MAPWCA, CHWS²

Corresponding Author: kevin.nolan_EXT@RestorixHealth.com

Affiliations

¹ Regional Medical Director, Midwest/MidAtlantic Regions, RestorixHealth, Metairie, LA, USA; Clinical Professor of Surgery, Wayne State University School of Medicine, Detroit, MI, USA; Clinical Professor of Surgery, Michigan State University College of Human Medicine, Lansing, MI, USA.

² Chief Medical Officer, RestorixHealth, Metairie, LA, USA; President, Wound and Hyperbaric Association, Park City, UT, USA; President, American Professional Wound Care Association, Milwaukee, WI, USA; Adjunct Assistant Professor of Undersea & Hyperbaric Medicine, Duke University School of Medicine, Durham, NC, USA; Adjunct Professor of Podiatric Medicine & Surgery, Western University of Health Sciences, Pomona, CA, USA.

Previous
Previous

Real-world outcomes of a placenta-based tissue product versus standard of care for lower extremity diabetic ulcers: A Medicare cohort study

Next
Next

Recommendations to inform National Coverage Determination development for skin substitutes in hard-to-heal wounds